You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TK2

Showing 1 - 25 of 1,715
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A RETROspective Study of Patients With TK2d

Completed
  • Thymidine Kinase 2 (TK2)
  • New York, New York
  • +7 more
Oct 3, 2022

Thymidine Kinase 2 Deficiency Trial (MT1621)

Withdrawn
  • Thymidine Kinase 2 Deficiency
  • (no location specified)
Aug 16, 2022

Mitochondrial DNA Depletion Syndrome 2 Myopathic Type, Thymidine Kinase 2 Deficiency Trial in New York (Thymidine)

Active, not recruiting
  • Mitochondrial DNA Depletion Syndrome 2 Myopathic Type
  • Thymidine Kinase 2 Deficiency
  • New York, New York
    Columbia University Irving Medical Center
Jul 28, 2022

Mucositis Trial in India (TK-112690, Placebo)

Recruiting
  • Mucositis
  • Bhopal, Madhya Pradesh, India
  • +4 more
Dec 19, 2022

Mucositis Trial in India (TK-112690, Placebo)

Recruiting
  • Mucositis
  • Srinagar, Jammu & Kashmir, India
  • +4 more
Dec 12, 2022

Acute Ischemic Stroke, Type 2 Diabetes Trial in Guangzhou (Urinary Kallidinogenase for injection, Placebo)

Not yet recruiting
  • Acute Ischemic Stroke
  • Type 2 Diabetes
  • Urinary Kallidinogenase for injection
  • Placebo
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital, Sun Yat-sen University
Oct 13, 2023

Ovarian Carcinoma Trial in Israel, United States (Denosumab, Salpingo-Oophorectomy)

Terminated
Has Results
  • Ovarian Carcinoma
  • Denosumab
  • Salpingo-Oophorectomy
  • Boston, Massachusetts
  • +5 more
May 23, 2022

Advanced Solid Tumors Trial in Belgium, Germany, Spain (Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR)

Recruiting
  • Advanced Solid Tumors
  • Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR
  • Ghent, Belgium
  • +2 more
Jun 23, 2022

Mucositis Trial in Bangalore, Navanagar, Kolkata (TK-112690, Placebo TK-112690)

Completed
Has Results
  • Mucositis
  • Bangalore, Karnataka, India
  • +2 more
May 8, 2021

Glioma, Malignant Trial in United States (biological, drug, radiation, other)

Active, not recruiting
  • Glioma, Malignant
  • AdV-tk
  • +5 more
  • Los Angeles, California
  • +7 more
Jan 30, 2023

Metastatic Hormone Sensitive Prostate Cancer Treated With

Not yet recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • Innsbruck, Austria
  • +42 more
Jun 5, 2023

Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)

Active, not recruiting
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +69 more
Apr 5, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (Group 1: TK216, Group 2: TK216, Part 2: Decitabine

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Group 1: TK216
  • +6 more
  • (no location specified)
May 2, 2019

Microbiome, Plasma Cholesterol, Prebiotic Trial in Cork (Hot Cereal)

Completed
  • Microbiome
  • +2 more
  • Hot Cereal
  • Cork, Ireland
    Atlantia Food Clinical Trials
Dec 3, 2019

Healthy Trial in Germany (TK-254RX)

Not yet recruiting
  • Healthy
  • Brühl, Germany
  • +3 more
Sep 14, 2023

Primary Mitochondrial Myopathies Trial in Madrid

Not yet recruiting
  • Primary Mitochondrial Myopathies
    • Madrid, Spain
      Hospital Universitario 12 Octubre
    Dec 7, 2022

    Subjects With Thymidine Kinase 2 Deficiency

    Completed
    • Thymidine Kinase 2 Deficiency
    • Observational retrospective data
    • Los Angeles, California
    • +11 more
    Mar 10, 2022

    Metastatic Osteosarcoma, Recurrent Osteosarcoma, Refractory Osteosarcoma Trial in Canada, Puerto Rico, United States (Denosumab,

    Active, not recruiting
    Has Results
    • Metastatic Osteosarcoma
    • +5 more
    • Denosumab
    • +2 more
    • Birmingham, Alabama
    • +140 more
    Apr 27, 2022

    Blood and Tumor Samples From Advanced or Metastatic Estrogen

    Active, not recruiting
    • Advanced Breast Carcinoma
    • +8 more
    • Biopsy
    • +2 more
    • Scottsdale, Arizona
    • +2 more
    Jan 3, 2023

    Sarcoma, Ewing Trial in China (TK216+Vincristin)

    Not yet recruiting
    • Sarcoma, Ewing
    • TK216+Vincristin
    • Beijing, Beijing, China
    • +7 more
    Jul 25, 2022

    Urinary Bladder Tumors Trial in Worldwide (TAR-200, Cetrelimab)

    Recruiting
    • Urinary Bladder Neoplasms
    • Phoenix, Arizona
    • +183 more
    Jan 27, 2023

    Personalised Disease Monitoring in Metastatic Breast Cancer

    Recruiting
    • Breast Cancer Metastatic
    • Estrogen Receptor-positive Breast Cancer
      • Gothenburg, Sweden
      • +6 more
      Dec 7, 2022

      Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

      Active, not recruiting
      Has Results
      • Metastatic Non-small Cell Lung Cancer
      • Metastatic Triple-negative Breast Cancer
      • ADV/HSV-tk
      • +3 more
      • Houston, Texas
        Houston Methodist Cancer Center
      Dec 28, 2022

      Peripheral Arterial Disease Trial in Worldwide (IN.PACT Admiral™ Drug Eluting Balloon)

      Completed
      Has Results
      • Peripheral Arterial Disease
      • IN.PACT Admiral™ Drug Eluting Balloon
      • Buenos Aires, Argentina
      • +64 more
      Mar 2, 2021

      COVID-19 Trial in Worldwide (Placebo, Remdesivir)

      Completed
      Has Results
      • COVID-19
      • Birmingham, Alabama
      • +59 more
      Mar 9, 2022